WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 2-Jul-2015 (Data received as of 26-June-2015)
Next overall update Mid July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 3'5701 Infant (under 12 months) mortality rate: 182
GDP / capita (US$): 7'1651 Child (under 5 years) mortality rate: 202

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 4'323  4'341  4'358  4'374  4'389  4'744  5'460  5'073 
Births 57  58  59  60  61  57  91  95 
Surviving infants 56  57  58  59  59  55  87  90 
Pop. less than 5 years 289  298  306  306  294  276  458  434 
Pop. less than 15 years 785  777  771  766  759  1'040  1'344  1'308 
Female 15-49 years 1'049  1'075  1'101  1'126  1'149  1'236  1'348  1'325 

Number of reported case

(Click for retrospective incidence data for Georgia)
Diphtheria 28 
Japanese encephalitis
Measles 3'188  7'872  31  64  22  50 
Mumps 55  52  50  44  101  2'646 
Pertussis 94  115  346  33  49  84 
Polio*
Rubella 149  224  75  64  59  428 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Georgia)
Vaccine year result method % card seen                                                
BCG 1998  92  EPI   86  96  95  95  96  97  95 
DTP1 1998  87  EPI   86  99*  99*  94  95  99*  99 
DTP3 1998  80  EPI   86  91  98  92  95  91  98 
HepB_BD          95  80  93  93  90 
HepB3          91  93  92  92  95  55 
Hib3          91  93  92  92  67 
JapEnc         
MCV          92  97  93  94  94  97 
MCV2          87  89  84  77  84 
PCV1          10 
PCV3         
Pol3 1998  80  EPI   86  91  94  93  91  88  98 
Rota1          77  74 
Rota_last          69  56 
Rubella1          92  97  93  94  94 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Georgia)
BCG 95  95  96  96  95 
DTP1 99  94  95  99  89 
DTP3 98  92  94  91  80 
HepB3 93  92  92  95  55 
HepB_BD 93  93  93  90 
Hib3 93  92  92  67 
MCV 96  93  94  94  73 
MCV2 89  84  77  84 
PCV3
Pol3 94  93  90  88  81 
Rota_last 41 

Number of districts in the country 65  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 68
From 80 to 89% 26
From 50 to 79% 6
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 0-5 days; Yes
DT 5 years; Yes
DTwP 18 months; Yes
DTwPHibHepB 2, 3, 4 months; Yes
HepB_Pediatric birth; Yes
Influenza_Adult Yes For health care workers and other risk groups
MMR 12 months; 5 years; Yes
OPV 2, 3, 4, 18 months; 5 years; Yes
Pneumo_conj 2, 3, 12 months; Yes
Rotavirus 2, 3 months; Yes
Td 14 years; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2012-2016  2010/2015  2007-2010  2007-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 65  65  65  65  63  65  66 

System performance

Total Nº districts in country number 65  65  65  65  65  65  66 
Nº districts with DTP3 coverage >=80% number 61  61  59  62  55  55  58 
% of districts with DTP3 coverage >=80% From 0 to 100% 94  94  91  95  85  85  88 
Nº districts with measles (MCV1) coverage >=95% number 32  41  31  35  43  45 
% of districts with MCV1 coverage >=95% From 0 to 100% 49  63  48  54  66  68 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 77  49  38  100  64  97  68,4 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.